Literature DB >> 8486141

Population kinetics of gentamicin in neonates.

W Weber1, G Kewitz, K L Rost, M Looby, M Nitz, L Harnisch.   

Abstract

A population kinetic analysis was carried out on sparse plasma gentamicin (GE) concentration data from 469 neonates obtained as part of a routine therapeutic drug monitoring (TDM) programme in the hospital neonatology unit. The best predictors of the kinetic parameters of the monoexponential model, volume of distribution (Vd) and clearance (CL), were the weight (WT) and gestational age (GA). Vd of the neonates was only related to WT, whereas the half-life was only related to the GA. The clinical implications of the findings are that the initial dose per WT administered to premature infants should be larger than that for term infants, because of a larger Vd per unit WT, and the intervals between maintenance doses should extended due to the prolonged half-life. Apart from these general guidelines, specific dose recommendations are also given.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486141     DOI: 10.1007/bf01428387

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Single or multiple daily doses of aminoglycosides. More details needed of treatment in neonates and young children.

Authors:  H Campbell
Journal:  BMJ       Date:  1996-08-24

Review 2.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

3.  Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.

Authors:  Aline Fuchs; Monia Guidi; Eric Giannoni; Dominique Werner; Thierry Buclin; Nicolas Widmer; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

4.  Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus.

Authors:  D J Touw; J H Proost; R Stevens; H N Lafeber; M M van Weissenbruch
Journal:  Pharm World Sci       Date:  2001-10

5.  Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations.

Authors:  Tamara van Donge; Marc Pfister; Julia Bielicki; Chantal Csajka; Frederique Rodieux; John van den Anker; Aline Fuchs
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

6.  Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya.

Authors:  Alison H Thomson; Gilbert O Kokwaro; Simon N Muchohi; Michael English; Shebbe Mohammed; Geoffrey Edwards
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

7.  Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.

Authors:  Elisabet I Nielsen; Marie Sandström; Per Hartvig Honoré; Uwe Ewald; Lena E Friberg
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

8.  Population pharmacokinetics of gentamicin in South African newborns.

Authors:  J H Botha; M J du Preez; M Adhikari
Journal:  Eur J Clin Pharmacol       Date:  2003-10-18       Impact factor: 2.953

9.  Special population considerations and regulatory affairs for clinical research.

Authors:  Kristin N Grimsrud; Catherine M T Sherwin; Jonathan E Constance; Casey Tak; Athena F Zuppa; Michael G Spigarelli; Nicole L Mihalopoulos
Journal:  Clin Res Regul Aff       Date:  2015

Review 10.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.